Metabolites
Displaying metabolites 1351 - 1375 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB24776 | DG(14:0/15:0cyclo/0:0) | (2S)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl tetradecanoate | phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/14:0/15:0cyclo) PW001182 | 524.827 C32H60O5 | |
ECMDB24784 | DG(15:0cyclo/14:0/0:0) | (2R)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl tetradecanoate | phospholipid biosynthesis CL(16:0/15:0cyclo/15:0cyclo/14:0) PW001221 | 524.827 C32H60O5 | |
ECMDB24804 | DG(17:0cycw7c/12:0/0:0) | (2R)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl dodecanoate | phospholipid biosynthesis (CL(17:0cycw7c/12:0/12:0/12:0)) PW001972 | 524.827 C32H60O5 | |
ECMDB24826 | DG(19:0cycw8c/10:0/0:0) | (2R)-3-{[9-(2-heptylcyclopropyl)nonanoyl]oxy}-2-hydroxypropyl decanoate | phospholipid biosynthesis (CL(19:0cycw8c/10:0/10:0/10:0)) PW001994 | 524.827 C32H60O5 | |
ECMDB23249 | DG(10:0/19:1(9Z)/0:0) | (2S)-3-(decanoyloxy)-2-hydroxypropyl (9Z)-nonadec-9-enoate | 524.827 C32H60O5 | ||
ECMDB23313 | DG(19:1(9Z)/10:0/0:0) | (2R)-3-(decanoyloxy)-2-hydroxypropyl (9Z)-nonadec-9-enoate | phospholipid biosynthesis (PE(19:iso/10:0)) PW001786 | 524.827 C32H60O5 | |
ECMDB23777 | L-Lysyl-tRNA | {[(1R,10R,16R)-5-amino-7,13,13-trioxo-17-oxa-12,14-dithia-2,4,6,9-tetraaza-13-molybdatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),5,11(15)-trien-16-yl]methoxy}phosphonic acid | 525.31 C10H16MoN5O8PS2 | ||
ECMDB23792 | Molybdoenzyme molybdenum cofactor 73508-07-3 | {[(1R,10R,16R)-5-amino-7,13,13-trioxo-17-oxa-12,14-dithia-2,4,6,9-tetraaza-13-molybdatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-3(8),5,11(15)-trien-16-yl]methoxy}phosphonic acid | 525.31 C10H16MoN5O8PS2 | ||
ECMDB24828 | DG(19:iso/10:0/0:0) | 2-(decanoyloxy)-3-hydroxypropyl 17-methyloctadecanoate | phospholipid biosynthesis (CL(19:iso/10:0/19:iso/10:0)) PW001998 | 526.843 C32H62O5 | |
ECMDB23262 | DG(14:0/15:0/0:0) | (2S)-2-hydroxy-3-(tetradecanoyloxy)propyl pentadecanoate | 526.843 C32H62O5 | ||
ECMDB23270 | DG(15:0/14:0/0:0) | (2R)-2-hydroxy-3-(tetradecanoyloxy)propyl pentadecanoate | phospholipid biosynthesis CDP-DG(15:0/14:0) PW001807 | 526.843 C32H62O5 | |
ECMDB23236 | molybdenum cofactor 73508-07-3 | molybdenum(2+) ion ({4-hydroxy-2-imino-6,7-disulfanyl-1H,2H,5H,5aH,8H,9aH,10H-pyrano[3,2-g]pteridin-8-yl}methoxy)phosphonic acid dihydrate | GTP degradation PW001888 | 527.32 C10H18MoN5O8PS2 | |
ECMDB24770 | DG(14:0(3-OH)/14:0/0:0) | (2R)-2-hydroxy-3-(tetradecanoyloxy)propyl 3-hydroxytetradecanoate | phospholipid biosynthesis (CL(14:0(3-OH)/14:0/14:0/14:0)) PW001937 | 528.815 C31H60O6 | |
ECMDB24775 | DG(14:0/14:0(3-OH)/0:0) | (2S)-2-hydroxy-3-(tetradecanoyloxy)propyl 3-hydroxytetradecanoate | phospholipid biosynthesis (CL(14:0/14:0(3-OH)/14:0/14:0)) PW001944 | 528.815 C31H60O6 | |
ECMDB21293 | UDP-4-Keto-pyranose | 1-[(3R,4S,5R)-5-{[({[(2R,3R,4R)-3,4-dihydroxy-5-oxooxan-2-yl]oxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-olate | 532.244 C14H18N2O16P2 | ||
ECMDB21653 | Galactan 39300-87-3 | (2S,3R,4S,5S,6S)-5-{[(2R,3R,4S,5R,6S)-5-{[(2R,3R,4R,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)-2-methoxyoxane-3,4-diol | 532.4902 C20H36O16 | ||
ECMDB23202 | UDP-beta-L-Threo-pentapyranos-4-ulose | {[(2R,3S,4R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}[({[(2R,3R,4R)-3,4-dihydroxy-5-oxooxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphinic acid | 534.2599 C14H20N2O16P2 | ||
ECMDB24240 | UDP-β-L-threo-pentapyranos-4-ulose | [({[(2R,3R,4R)-3,4-dihydroxy-5-oxooxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid | 534.26 C14H20N2O16P2 | ||
ECMDB21366 | Uridine 5''-diphospho-{beta}-4-deoxy-4-amino-L-arabinose | 1-[(2R,3R,4S,5R)-5-[({[({[(2R,3R,4S,5S)-5-amino-3,4-dihydroxyoxan-2-yl]oxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-olate | 534.2831 C14H22N3O15P2 | ||
ECMDB21497 | 4-Amino-4-deoxy-L-arabinose | [({[(2R,3R,4S,5S)-5-amino-3,4-dihydroxyoxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid | One Carbon Pool by Folate I PW001735 | 535.291 C14H23N3O15P2 | |
ECMDB20170 | Lipoyl-AMP | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[5-(1,2-dithiolan-3-yl)pentanoyl]oxy})phosphinic acid | Lipoic acid metabolism PW000770 | 535.532 C18H26N5O8PS2 | |
ECMDB24785 | DG(15:0cyclo/15:0cyclo/0:0) | 3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl 8-(2-butylcyclopropyl)octanoate | phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/16:0) PW001059 | 536.838 C33H60O5 | |
ECMDB24345 | DG(18:1(11Z)/12:0/0:0) | (2R)-3-(dodecanoyloxy)-2-hydroxypropyl (11Z)-octadec-11-enoate | phospholipid biosynthesis (CL(18:1(11Z)/12:0/12:0/12:0)) PW001977 | 538.854 C33H62O5 | |
ECMDB23257 | DG(12:0/18:1(9Z)/0:0) | (2S)-3-(dodecanoyloxy)-2-hydroxypropyl (9Z)-octadec-9-enoate | 538.854 C33H62O5 | ||
ECMDB23264 | DG(14:0/16:1(9Z)/0:0) | (2S)-2-hydroxy-3-(tetradecanoyloxy)propyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis CL(16:0/14:0/14:0/16:1(9Z)) PW001206 | 538.854 C33H62O5 |